BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Biologics

EpiVax Grants ISPRI Toolkit License to Eisai for Preclinical Immunogenicity Screening

The ISPRI toolkit is a secure web-based platform that allows researchers to rapidly assess the immunogenic risk of biologic candidates. The fu...

December 21, 2023 | News

InxMed Licenses Next-Gen ADCs with Escugen

The license agreement provides InxMed with right to use EZWi-Fit® platform on the several novel ADC candidate molecules. InxMed will hav...

December 20, 2023 | News

NUS Researchers in Singapore Innovate Flexible Method for Immune Cell Study

Our body's immune system is a complex network of organs, cells, and proteins that work in synchrony to protect our bodies against infections caused by path...

December 19, 2023 | News

Illumina Announces Decision to Divest GRAIL

The divestiture will be executed through a third-party sale or capital markets transaction, consistent with the European Commission's divestiture o...

December 18, 2023 | News

GeneQuantum and BioMap Collaborate on Next-Gen ADC Therapeutics

The partnership will combine GQ's proprietary enzymatic site-specific conjugation technology platforms (iLDC® and iGDC®), linker-payload platform, ...

December 18, 2023 | News

Nona Biosciences and Pfizer Strike Global Deal for MSLN-Targeted ADC HBM9033

Under the terms of the agreement, Nona Biosciences will receive a total of up to $53 million in upfront and near-term payments, with the potentia...

December 15, 2023 | News

Modalis and JCR Pharmaceuticals enter into joint research agreement

Modalis Therapeutics Corporation (Modalis) (Tokyo Stock Exchange: 4883) announced that it has entered into a joint research agreement with JCR Pharma...

December 14, 2023 | News

Molecular Loop Biosciences Secures $1.8M to Expand Multi-pathogen Genomics for Respiratory Infections

"This grant from the foundation will support our commitment to expanding access to NGS with LoopCap™ technology. LoopCap addresses challenges in...

December 14, 2023 | News

MGI Broadens Latin American Presence with Genos Médica and TCL Group Partnerships

"Over the last four years, we have witnessed rapid growth in the high-throughput sequencing market in Latin America and are confident in its upwa...

December 13, 2023 | News

Illumina and HaploX Collaborate on Benchtop Sequencing System

This marks a new stage in the strategic partnership between the two companies. In the future, Illumina and HaploX will take the localized manufacturing of ...

December 13, 2023 | News

Inside the World of Cell Therapies: Illuminating the Future of Cancer Care

The Rise of Cell Therapies in Cancer Care Recent years have witnessed significant strides in the development and application of cell therapies for cancer ...

December 13, 2023 | News

CSL Behring's HEMGENIX® Shows Long-Term Durability and Safety in Hemophilia B

HEMGENIX® is the first and only gene therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of he...

December 12, 2023 | News

Whole Exome Sequencing Advancements in Unraveling Rare Diseases in Japan

The Rare Disease Diagnosis and Intractable Disease Research Center at Juntendo University has improved its diagnostic capabilities by combining research ...

December 11, 2023 | News

Nona Biosciences Announces Collaboration with Evive Biotech to Accelerate Antibody Discovery

The collaboration brings together professional advantages of Nona Biosciences and Evive Biotech, aiming to accelerate the process of antibody discovery and...

December 11, 2023 | News

Stay Connected